{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:12:58Z","timestamp":1775862778282,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vascn.2024.107572","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T15:10:06Z","timestamp":1734275406000},"page":"107572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Demonstrating the statistical and pharmacological sensitivity of nonclinical QTc analysis using a dofetilide dose\u2013response in nonhuman primates"],"prefix":"10.1016","volume":"131","author":[{"given":"Derek J.","family":"Leishman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek D.","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107572_bb0005","series-title":"ICH E14\/S7B Implementation Working Group - Clinical and Nonclinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential. Questions and Answers","author":"Anonymous","year":"2022"},{"key":"10.1016\/j.vascn.2024.107572_bb0010","series-title":"ICH_E14-S7B Training Material Examples Supplemental File 2022_0331.pdf","author":"Anonymous","year":"2022"},{"issue":"2","key":"10.1016\/j.vascn.2024.107572_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/cvr\/cvp213","article-title":"Reverse rate dependency is an intrinsic property of canine cardiac preparations","volume":"84","author":"Banyasz","year":"2009","journal-title":"Cardiovascular Research"},{"issue":"10","key":"10.1016\/j.vascn.2024.107572_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70046","article-title":"A \u201cone-step\u201d approach to heart rate correction and statistical analysis applied to conscious dog QTc studies","volume":"17","author":"Best","year":"2024","journal-title":"Clinical and Translational Science"},{"issue":"2","key":"10.1016\/j.vascn.2024.107572_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vascn.2006.02.004","article-title":"A one-step approach to the analysis of the QT interval in conscious telemetrized dogs","volume":"54","author":"Chiang","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"11","key":"10.1016\/j.vascn.2024.107572_bb0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jcph.2309","article-title":"The New S7B\/E14 Q&A Document Provides Additional Opportunities to Replace the Thorough QT Study","volume":"63","author":"Darpo","year":"2023","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107572_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.CIR.83.2.536","article-title":"Rate Dependence of Sotalol-Induced Prolongation of Ventricular Repolarization During Exercise in Humans","volume":"83","author":"Funck-Bretano","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2024.107572_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107253","article-title":"Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation","volume":"120","author":"Holdsworth","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"10.1016\/j.vascn.2024.107572_bb0045","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clpt.2005.02.004","article-title":"A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data","volume":"77","author":"Jonker","year":"2005","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107572_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","article-title":"Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide","volume":"72","author":"Jurkiewicz","year":"1993","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107572_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106606","article-title":"Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human","volume":"99","author":"Komatsu","year":"2019","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"11","key":"10.1016\/j.vascn.2024.107572_bb0060","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/cts.13625","article-title":"The \u201cOne-Step\u201d approach for QT analysis increases the sensitivity of nonclinical QTc analysis","volume":"16","author":"Leishman","year":"2023","journal-title":"Clinical and Translational Science"},{"issue":"5","key":"10.1016\/j.vascn.2024.107572_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1292\/jvms.62.491","article-title":"D0870, an antifungal agent, induces reverse use-dependent QT prolongation in dogs","volume":"62","author":"Matsunaga","year":"2000","journal-title":"The Journal of Veterinary Medical Science"},{"issue":"1","key":"10.1016\/j.vascn.2024.107572_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1538\/expanim.19-0009","article-title":"Establishment of a new formula for QT interval correction using a large colony of cynomolgus monkeys","volume":"69","author":"Nakayama","year":"2020","journal-title":"Experimental Animals"},{"key":"10.1016\/j.vascn.2024.107572_bb0075","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2022"},{"issue":"e0146021","key":"10.1016\/j.vascn.2024.107572_bb0080","article-title":"Dose-Response Analysis Using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2024.107572_bb0085","article-title":"Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14\/S7B Q&As","volume":"107270","author":"Rossman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2024.107572_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","article-title":"Population Marginal Means in the Linear Model: An Alternative to Least Squares Means","volume":"34","author":"Searle","year":"1980","journal-title":"The American Statistician"},{"issue":"7","key":"10.1016\/j.vascn.2024.107572_bb0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.hrthm.2005.03.023","article-title":"Refining detection of drug-induced proarrhythmia: QT interval and TRIaD","volume":"2","author":"Shah","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2024.107572_bb0100","article-title":"Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14\/S7B Updates)","author":"Strauss","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107572_bb0105","article-title":"Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective","author":"Vargas","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107572_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107265","article-title":"Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute","volume":"121","author":"Vargas","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T08:27:52Z","timestamp":1738657672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"alternative-id":["S1056871924000820"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107572","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demonstrating the statistical and pharmacological sensitivity of nonclinical QTc analysis using a dofetilide dose\u2013response in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107572"}}